Related references
Note: Only part of the references are listed.Adenoviral vector transduction of the human deoxycytidine kinase gene enhances the cytotoxic and radiosensitizing effect of gemcitabine on experimental gliomas
T. Szatmari et al.
CANCER GENE THERAPY (2008)
Modulation of gemcitabine (2',2'-difluoro-2'-deoxycytidine) pharmacokinetics, metabolism, and Bioavailability in mice by 3,4,5,6-tetrahydrouridine
Jan H. Beumer et al.
CLINICAL CANCER RESEARCH (2008)
Modulation of human cytidine deaminase by specific aminoacids involved in the intersubunit interactions
S. Vincenzetti et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2008)
Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs
W. Knecht et al.
GENE THERAPY (2007)
Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner
Michael P. B. Sandrini et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Deoxyribonucleoside kinases activate nucleoside antibiotics in severely pathogenic bacteria
Michael P. B. Sandrini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors
Eiji Kikuchi et al.
CLINICAL CANCER RESEARCH (2007)
Non-homologous recombination of deoxyribonucleoside kinases from human and Drosophila melanogaster yields human-like enzymes with novel activities
Monica L. Gerth et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer
Shin Nakahira et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Functional studies of active-site mutants from Drosophila melanogaster deoxyribonucleoside kinase -: Investigations of the putative catalytic glutamate-arginine pair and of residues responsible for substrate specificity
Louise Egeblad-Welin et al.
FEBS JOURNAL (2007)
Cloning and characterization of an alternative splicing transcript of the gene coding for human cytidine deaminase
Blanca Cristina Garcia Lisboa et al.
BIOCHEMISTRY AND CELL BIOLOGY (2007)
Structural basis for activation of the therapeutic L-nucleoside analogs 3TC and troxacitabine by human deoxycytidine kinase
Elisabetta Sabini et al.
NUCLEIC ACIDS RESEARCH (2007)
Enhanced toxicity of purine nucleoside analogs in cells expressing Drosophila melanogaster nucleoside kinase mutants
N. Solaroli et al.
GENE THERAPY (2007)
Gene therapy based on gemcitabine chemosensitization suppresses pancreatic tumor growth
Fabienne Vernejoul et al.
MOLECULAR THERAPY (2006)
Gene transfer of cytidine deaminase protects myelopoiesis from cytidine analogs in an in vivo murine transplant model
Ina Rattmann et al.
BLOOD (2006)
Gemcitabine resistance due to deoxycytidine kinase deficiency can be reverted by fruitfly deoxynucleoside kinase, DmdNK, in human uterine sarcoma cells
LP Jordheim et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Gene therapy with drug resistance genes
M Zaboikin et al.
CANCER GENE THERAPY (2006)
Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics
JA Gilbert et al.
CLINICAL CANCER RESEARCH (2006)
The structure of human deoxycytidine kinase in complex with clofarabine reveals key interactions for prodrug activation
Y Zhang et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2006)
Transient expression of Drosophila melanogaster deoxynucleoside kinase gene enhances cytotoxicity of nucleoside analogs
Hiroyuki Kamiya et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2006)
Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells
W Bardenheuer et al.
LEUKEMIA (2005)
Hematopoietic stem cell gene therapy with drug resistance genes: an update
T Budak-Alpdogan et al.
CANCER GENE THERAPY (2005)
Altered deoxyribonucleotide pools in T-lymphoblastoid cells expressing the multisubstrate nucleoside kinase of Drosophila melanogaster
A Bertoli et al.
FEBS JOURNAL (2005)
Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells
LP Jordheim et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL):: identification of fludarabine-sensitive and -insensitive populations
JR Mackey et al.
BLOOD (2005)
Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the Escherichia coli purine nucleoside phosphorylase gene
JS Hong et al.
CANCER RESEARCH (2004)
Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene
T Budak-Alpdogan et al.
MOLECULAR THERAPY (2004)
Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer
R Martiniello-Wilks et al.
JOURNAL OF GENE MEDICINE (2004)
Gene-directed enzyme prodrug therapy for prostate cancer in a mouse model that imitates the development of human disease
R Martiniello-Wilks et al.
JOURNAL OF GENE MEDICINE (2004)
Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus
XY Wang et al.
GENE THERAPY (2004)
The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma
J Spratlin et al.
CLINICAL CANCER RESEARCH (2004)
An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines
JD Davidson et al.
CANCER RESEARCH (2004)
Action of troxacitabine on cells transduced with human cytidine deaminase cDNA
AJ Boivin et al.
CANCER INVESTIGATION (2004)
Designer gene therapy using an Escherichia coli purine nudeloside phosphorylase/prodrug system
EM Bennett et al.
CHEMISTRY & BIOLOGY (2003)
Active site mutants of Drosophila melanogaster multisubstrate deoxyribonucleoside kinase
N Solaroli et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Structure of human dCK suggests strategies to improve anticancer and antiviral therapy
E Sabini et al.
NATURE STRUCTURAL BIOLOGY (2003)
A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity
LJ Yue et al.
PHARMACOGENETICS (2003)
Forced expression of cytidine deaminase confers sensitivity to capecitabine
T Morita et al.
ONCOLOGY (2003)
Antitumor activity of 2-fluoro-2 '-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase
WB Parker et al.
CANCER GENE THERAPY (2003)
Current progress in suicide gene therapy for cancer
K Yazawa et al.
WORLD JOURNAL OF SURGERY (2002)
Gene therapy for prostate cancer delivered by ovine adenovirus and mediated by purine nucleoside phosphorylase and fludarabine in mouse models
D Voeks et al.
GENE THERAPY (2002)
Enhancement of cytarabine sensitivity in squamous cell carcinoma cell line transfected with deoxycytidine kinase
H Kojima et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2002)
Cytotoxic activity of 2′,2′-difluorodeoxycytidine, 5-aza-2′-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene
CM Beauséjour et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
A few amino acid substitutions can convert deoxyribonucleoside kinase specificity from pyrimidines to purines
W Knecht et al.
EMBO JOURNAL (2002)
Nucleoside analog cytotoxicity and bystander cell killing of cancer cells expressing Drosophila melanogaster deoxyribonucleoside kinase in the nucleus or cytosol
XY Zheng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Bystander effects of nucleoside analogs phosphorylated in the cytosol or mitochondria
A Sanda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Expression of high Km 5′-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia
CM Galmarini et al.
BLOOD (2001)
Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene
CM Beauséjour et al.
CANCER GENE THERAPY (2001)
Mechanisms of cell death induced by suicide genes encoding purine nucleoside phosphorylase and thymidine kinase in human hepatocellular carcinoma cells in vitro
TU Krohne et al.
HEPATOLOGY (2001)
Comparative study of a novel nucleoside analogue (Troxatyl, troxacitabine, BCH-4556) and AraC against leukemic human tumor xenografts expressing high or low cytidine deaminase activity
H Gourdeau et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)
Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft
P Tiberghien et al.
BLOOD (2001)
Retroviral transduction of cancer cell lines with the gene encoding Drosophila melanogaster multisubstrate deoxyribonucleoside kinase
XY Zheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells
VK Gadi et al.
GENE THERAPY (2000)
The subcellular location of nucleoside analog phosphorylation is a determinant of synergistic effects of hydroxyurea
CY Zhu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene
L Mohr et al.
HEPATOLOGY (2000)
Share Paper
